ADA members weigh in on perceptions of the ADA and association priorities.

J Am Dent Assoc

ADA Division of Membership and Dental Society Services, American Dental Association, Chicago, Ill 60611, USA.

Published: February 2003

Background: The American Dental Association conducted the 2000 Membership Needs and Opinions Survey to evaluate the professional needs and personal perceptions of ADA members on selected topics.

Methods: A questionnaire was sent to a sample of 6,310 ADA members in January 2000 with follow-up mailings in February, March and April 2000. Data collection was completed in July 2000. The survey included questions on critical professional issues, perceptions of the American Dental Association and its priorities. A total of 3,558 surveys were received for an adjusted response rate of 59.5 percent. Only professionally active dentists who were ADA members were included in the sampling frame.

Results: Members evaluated statements about the American Dental Association, revealing their perceptions of the ADA on key issues. Findings showed strong support for the ADA Seal program, agreement that the ADA enhances the integrity and ethics of the profession and that the ADA is the premier professional association for dentists. Findings also provided information regarding the relative importance of ADA priorities by allocating "dues dollars" in $5 increments. The highest priorities were "providing continuing education to dentists," "lobbying members of Congress and federal regulatory agencies" and "influencing national public health policy."

Conclusions: ADA members, both new and established dentists, had positive perceptions of the Association and its programs. Although there was general agreement between these groups concerning ADA priorities, there was a substantial difference between some subgroups (especially graduate students and federally employed dentists) and the overall membership on the issue of changes in the licensure process to facilitate dentists' freedom of movement.

Practice Implications: The Association should continue to take into account the membership's perceptions of the ADA and its priorities, as well as note issues of special interest to selected membership subgroups, in the planning and implementation of Association activities.

Download full-text PDF

Source
http://dx.doi.org/10.14219/jada.archive.2003.0136DOI Listing

Publication Analysis

Top Keywords

ada members
20
perceptions ada
16
ada
13
american dental
12
dental association
12
ada priorities
12
association
8
association priorities
8
perceptions
6
priorities
6

Similar Publications

Introduction: TNFα inhibitor (TNFi) immunogenicity in rheumatoid arthritis (RA) is a major obstacle to its therapeutic effectiveness. Although methotrexate (MTX) can mitigate TNFi immunogenicity, its adverse effects necessitate alternative strategies. Targeting nuclear factor of activated T cells (NFAT) transcription factors may protect against biologic immunogenicity.

View Article and Find Full Text PDF

Dissection of type 2 diabetes: a genetic perspective.

Lancet Diabetes Endocrinol

January 2025

Université de Lille, Inserm UMR1283, CNRS UMR8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, Lille University Hospital, Lille, France; Department of Metabolism, Imperial College London, London, UK. Electronic address:

Diabetes is a leading cause of global mortality and disability, and its economic burden is substantial. This Review focuses on type 2 diabetes, which makes up 90-95% of all diabetes cases. Type 2 diabetes involves a progressive loss of insulin secretion often alongside insulin resistance and metabolic syndrome.

View Article and Find Full Text PDF

Efforts to reduce sugar-sweetened beverages and combat childhood obesity.

Am J Clin Nutr

January 2025

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada; Global Health Graduate Program, McMaster University, Hamilton, ON, Canada; Population Health Research Institute, Hamilton, ON, Canada.

View Article and Find Full Text PDF

Background: Biosimilar natalizumab (biosim-NTZ) is the first biosimilar monoclonal antibody of reference natalizumab (ref-NTZ) for treatment of relapsing forms of multiple sclerosis (MS). Within the totality of evidence for demonstration of biosimilarity, immunogenicity assessments were performed in healthy subjects and patients with relapsing-remitting MS (RRMS) to confirm a matching immunogenicity profile between biosim-NTZ and ref-NTZ.

Methods: Immunogenicity of biosim-NTZ versus ref-NTZ was evaluated in two pivotal clinical studies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!